ANGO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Angiodynamics Inc (ANGO).


$252.74M Market Cap.

As of 07/25/2024 5:00 PM ET (MRY) • Disclaimer

ANGO Market Cap. (MRY)


ANGO Shares Outstanding (MRY)


ANGO Assets (MRY)


Total Assets

$317.67M

Total Liabilities

$112.08M

Total Investments

$0

ANGO Income (MRY)


Revenue

$303.91M

Net Income

-$184.35M

Operating Expense

$347.52M

ANGO Cash Flow (MRY)


CF Operations

-$28.16M

CF Investing

$123.72M

CF Financing

-$64.25M

ANGO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ANGO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$317,671,000 (-40.36%)

$532,637,000 (-3.64%)

$552,751,000 (-1.55%)

$561,438,000 (-5.52%)

Assets Current

$193,253,000 (18.17%)

$163,542,000 (14.09%)

$143,345,000 (1.75%)

$140,879,000 (-7.87%)

Assets Non-Current

$124,418,000 (-66.29%)

$369,095,000 (-9.85%)

$409,406,000 (-2.65%)

$420,559,000 (-4.70%)

Goodwill & Intangible Assets

$77,383,000 (-71.38%)

$270,382,000 (-23.50%)

$353,438,000 (-4.55%)

$370,293,000 (-6.88%)

Shareholders Equity

$205,586,000 (-45.65%)

$378,296,000 (-10.88%)

$424,489,000 (-3.41%)

$439,457,000 (-3.39%)

Property Plant & Equipment Net

$35,666,000 (-19.64%)

$44,384,000 (-1.38%)

$45,005,000 (21.40%)

$37,073,000 (30.94%)

Cash & Equivalents

$76,056,000 (70.45%)

$44,620,000 (54.80%)

$28,825,000 (-40.15%)

$48,161,000 (-11.53%)

Accumulated Other Comprehensive Income

-$4,365,000 (7.58%)

-$4,723,000 (-448.05%)

$1,357,000 (-56.96%)

$3,153,000 (335.12%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$60,616,000 (9.56%)

$55,325,000 (7.65%)

$51,392,000 (5.71%)

$48,614,000 (-18.85%)

Trade & Non-Trade Receivables

$43,610,000 (-17.45%)

$52,826,000 (1.00%)

$52,304,000 (47.73%)

$35,405,000 (13.25%)

Trade & Non-Trade Payables

$37,751,000 (-6.66%)

$40,445,000 (44.20%)

$28,047,000 (42.88%)

$19,630,000 (2.80%)

Accumulated Retained Earnings (Deficit)

-$395,204,000 (-87.43%)

-$210,855,000 (-33.10%)

-$158,413,000 (-20.13%)

-$131,866,000 (-31.45%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$4,852,000 (-62.13%)

$12,813,000 (-20.10%)

$16,037,000 (-19.63%)

$19,955,000 (-17.05%)

Total Debt

$0 (0%)

$49,818,000 (99.27%)

$25,000,000 (25.00%)

$20,000,000 (-50.00%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$49,818,000 (99.27%)

$25,000,000 (25.00%)

$20,000,000 (-50.00%)

Total Liabilities

$112,085,000 (-27.38%)

$154,341,000 (20.33%)

$128,262,000 (5.15%)

$121,981,000 (-12.46%)

Liabilities Current

$91,155,000 (8.74%)

$83,825,000 (12.78%)

$74,324,000 (29.07%)

$57,584,000 (11.93%)

Liabilities Non-Current

$20,930,000 (-70.32%)

$70,516,000 (30.74%)

$53,938,000 (-16.24%)

$64,397,000 (-26.74%)

ANGO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$303,914,000 (-10.28%)

$338,752,000 (7.13%)

$316,219,000 (8.66%)

$291,010,000 (10.17%)

Cost of Revenue

$149,216,000 (-9.29%)

$164,506,000 (9.32%)

$150,487,000 (12.12%)

$134,222,000 (17.86%)

Selling General & Administrative Expense

$143,982,000 (-0.19%)

$144,252,000 (7.85%)

$133,752,000 (14.10%)

$117,224,000 (0.62%)

Research & Development Expense

$31,512,000 (5.45%)

$29,883,000 (-2.78%)

$30,739,000 (-15.53%)

$36,390,000 (22.60%)

Operating Expenses

$347,518,000 (55.38%)

$223,661,000 (15.42%)

$193,781,000 (0.99%)

$191,890,000 (-41.68%)

Interest Expense

-$1,614,000 (-159.73%)

$2,702,000 (292.73%)

$688,000 (-20.09%)

$861,000 (-5.07%)

Income Tax Expense

-$7,289,000 (-265.36%)

-$1,995,000 (41.36%)

-$3,402,000 (24.47%)

-$4,504,000 (-234.12%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$184,349,000 (-251.53%)

-$52,442,000 (-97.54%)

-$26,547,000 (15.85%)

-$31,548,000 (81.08%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$184,349,000 (-251.53%)

-$52,442,000 (-97.54%)

-$26,547,000 (15.85%)

-$31,548,000 (81.08%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$184,349,000 (-251.53%)

-$52,442,000 (-97.54%)

-$26,547,000 (15.85%)

-$31,548,000 (81.08%)

Weighted Average Shares

$40,181,000 (1.78%)

$39,480,000 (1.21%)

$39,009,000 (1.74%)

$38,342,000 (1.00%)

Weighted Average Shares Diluted

$40,181,000 (1.78%)

$39,480,000 (1.21%)

$39,009,000 (1.74%)

$38,342,000 (1.00%)

Earning Before Interest & Taxes (EBIT)

-$193,252,000 (-273.54%)

-$51,735,000 (-76.81%)

-$29,261,000 (16.85%)

-$35,191,000 (78.96%)

Gross Profit

$154,698,000 (-11.22%)

$174,246,000 (5.14%)

$165,732,000 (5.70%)

$156,788,000 (4.34%)

Operating Income

-$192,820,000 (-290.21%)

-$49,415,000 (-76.17%)

-$28,049,000 (20.09%)

-$35,102,000 (80.36%)

ANGO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$123,717,000 (1369.41%)

-$9,746,000 (49.52%)

-$19,307,000 (-40.81%)

-$13,711,000 (78.36%)

Net Cash Flow from Financing

-$64,248,000 (-352.75%)

$25,420,000 (230.86%)

$7,683,000 (145.23%)

-$16,986,000 (82.17%)

Net Cash Flow from Operations

-$28,158,000 (-36200.00%)

$78,000 (101.08%)

-$7,194,000 (-129.86%)

$24,093,000 (265.54%)

Net Cash Flow / Change in Cash & Cash Equivalents

$31,436,000 (99.03%)

$15,795,000 (181.69%)

-$19,336,000 (-208.19%)

-$6,274,000 (96.38%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

-$3,600,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$126,967,000 (1479.18%)

-$9,206,000 (41.39%)

-$15,707,000 (-14.56%)

-$13,711,000 (-89.51%)

Issuance (Repayment) of Debt Securities

-$50,000,000 (-300.00%)

$25,000,000 (400.00%)

$5,000,000 (125.00%)

-$20,000,000 (78.38%)

Issuance (Purchase) of Equity Shares

$752,000 (-35.78%)

$1,171,000 (-56.35%)

$2,683,000 (-10.98%)

$3,014,000 (497.10%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$125,000 (190.70%)

$43,000 (108.30%)

-$518,000 (-256.97%)

$330,000 (607.69%)

Share Based Compensation

$10,529,000 (-5.64%)

$11,158,000 (4.36%)

$10,692,000 (23.97%)

$8,625,000 (13.61%)

Depreciation Amortization & Accretion

$29,643,000 (-11.13%)

$33,357,000 (4.94%)

$31,788,000 (12.04%)

$28,372,000 (9.65%)

ANGO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

50.90% (-0.97%)

51.40% (-1.91%)

52.40% (-2.78%)

53.90% (-5.27%)

Profit Margin

-60.70% (-291.61%)

-15.50% (-84.52%)

-8.40% (22.22%)

-10.80% (82.88%)

EBITDA Margin

-53.80% (-896.30%)

-5.40% (-775.00%)

0.80% (134.78%)

-2.30% (95.70%)

Return on Average Equity (ROAE)

-58.80% (-348.85%)

-13.10% (-111.29%)

-6.20% (11.43%)

-7.00% (75.95%)

Return on Average Assets (ROAA)

-45.10% (-369.79%)

-9.60% (-100.00%)

-4.80% (11.11%)

-5.40% (77.78%)

Return on Sales (ROS)

-63.60% (-315.69%)

-15.30% (-64.52%)

-9.30% (23.14%)

-12.10% (80.88%)

Return on Invested Capital (ROIC)

-213.10% (-591.88%)

-30.80% (-32.19%)

-23.30% (17.38%)

-28.20% (83.96%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.38 (80.67%)

-7.11 (75.36%)

-28.87 (-2.39%)

-28.2 (-1112.17%)

Price to Sales Ratio (P/S)

0.83 (-24.39%)

1.1 (-54.46%)

2.42 (-20.49%)

3.05 (107.63%)

Price to Book Ratio (P/B)

1.23 (25.28%)

0.98 (-45.29%)

1.79 (-10.62%)

2.01 (137.12%)

Debt to Equity Ratio (D/E)

0.55 (33.58%)

0.41 (35.10%)

0.3 (8.63%)

0.28 (-9.15%)

Earnings Per Share (EPS)

-4.59 (-245.11%)

-1.33 (-95.59%)

-0.68 (17.07%)

-0.82 (81.32%)

Sales Per Share (SPS)

7.56 (-11.84%)

8.58 (5.85%)

8.11 (6.80%)

7.59 (9.07%)

Free Cash Flow Per Share (FCFPS)

2.46 (1164.50%)

-0.23 (60.65%)

-0.59 (-316.61%)

0.27 (147.21%)

Book Value Per Share (BVPS)

5.12 (-46.61%)

9.58 (-11.95%)

10.88 (-5.06%)

11.46 (-4.35%)

Tangible Assets Book Value Per Share (TABVPS)

5.98 (-9.98%)

6.64 (30.03%)

5.11 (2.49%)

4.99 (-3.73%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (87.50%)

-8 (69.23%)

-26 (-8.33%)

-24 (-1100.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.06 (94.99%)

-21.27 (-107.05%)

301.69 (339.97%)

-125.72 (-4676.48%)

Asset Turnover

0.74 (20.23%)

0.62 (7.85%)

0.57 (13.92%)

0.5 (30.65%)

Current Ratio

2.12 (8.66%)

1.95 (1.14%)

1.93 (-21.14%)

2.45 (-17.70%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$98,809,000 (1182.48%)

-$9,128,000 (60.14%)

-$22,901,000 (-320.58%)

$10,382,000 (147.65%)

Enterprise Value (EV)

$174,293,103 (-55.41%)

$390,872,552 (-48.73%)

$762,363,383 (-11.07%)

$857,266,925 (130.42%)

Earnings Before Tax (EBT)

-$191,638,000 (-252.04%)

-$54,437,000 (-81.77%)

-$29,949,000 (16.93%)

-$36,052,000 (78.56%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$163,609,000 (-790.24%)

-$18,378,000 (-827.27%)

$2,527,000 (137.06%)

-$6,819,000 (95.18%)

Invested Capital

$73,077,000 (-60.20%)

$183,628,000 (51.55%)

$121,164,000 (14.96%)

$105,400,000 (-19.35%)

Working Capital

$102,098,000 (28.08%)

$79,717,000 (15.50%)

$69,021,000 (-17.14%)

$83,295,000 (-17.91%)

Tangible Asset Value

$240,288,000 (-8.38%)

$262,255,000 (31.58%)

$199,313,000 (4.27%)

$191,145,000 (-2.76%)

Market Capitalization

$252,744,103 (-31.91%)

$371,176,552 (-51.24%)

$761,253,383 (-13.66%)

$881,735,925 (129.10%)

Average Equity

$313,328,500 (-21.57%)

$399,487,500 (-7.23%)

$430,624,750 (-4.51%)

$450,947,500 (-21.34%)

Average Assets

$409,021,250 (-25.34%)

$547,836,250 (-0.66%)

$551,448,750 (-4.76%)

$578,990,750 (-15.52%)

Invested Capital Average

$90,705,000 (-46.00%)

$167,979,250 (33.87%)

$125,483,250 (0.52%)

$124,833,250 (31.23%)

Shares

40,054,533 (2.09%)

39,236,422 (1.18%)

38,780,101 (1.69%)

38,137,367 (1.17%)